Get the Stockscreener App
1.94
1.02%
-0.02
After Hours:
1.95
0.01
+0.52%
Bluejay Diagnostics Inc stock is traded at $1.94, with a volume of 6,043.
It is down -1.02% in the last 24 hours and down -4.43% over the past month.
Bluejay Diagnostics Inc is a medical diagnostics company focused on improving patient outcomes using its Symphony System, a cost-effective, rapid, near-patient testing system for sepsis triage and monitoring of disease progression. Bluejay's first product candidate, an IL-6 Test for sepsis, is designed to provide accurate, reliable results in approximately 20 minutes from sample-to-result to help medical professionals make earlier and quicker triage/treatment decisions.
See More
Previous Close:
$1.96
Open:
$1.94
24h Volume:
6,043
Relative Volume:
0.04
Market Cap:
$2.01M
Revenue:
-
Net Income/Loss:
$-6.85M
P/E Ratio:
-0.1257
EPS:
-15.4314
Net Cash Flow:
$-6.23M
1W Performance:
+4.86%
1M Performance:
-4.43%
6M Performance:
-68.91%
1Y Performance:
-87.37%
1-Day Range:
$1.85
$1.95
1-Week Range:
$1.78
$2.05
52-Week Range:
$1.70
$40.80
Bluejay Diagnostics Inc Stock (BJDX) Company Profile
Name
Bluejay Diagnostics Inc
Sector
Industry
Phone
(978) 631-0152
Address
360 MASSACHUSETTS AVENUE, SUITE 203, ACTON
Compare BJDX vs ABT, SYK, MDT, BSX, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
BJDX
Bluejay Diagnostics Inc
|
1.94 | 2.03M | 0 | -6.85M | -6.23M | -15.43 |
ABT
Abbott Laboratories
|
104.83 | 180.82B | 44.33B | 6.50B | 7.40B | 3.717 |
SYK
Stryker Corp
|
327.65 | 125.72B | 25.12B | 3.25B | 4.28B | 8.3984 |
MDT
Medtronic Plc
|
87.89 | 111.16B | 35.48B | 4.64B | 5.41B | 3.582 |
BSX
Boston Scientific Corp
|
69.78 | 101.28B | 20.08B | 2.89B | 3.66B | 1.9391 |
EW
Edwards Lifesciences Corp
|
82.67 | 47.45B | 6.07B | 1.06B | 1.34B | 1.8063 |
Bluejay Diagnostics Inc Stock (BJDX) Latest News
BJDX SEC FilingsBluejay Diagnostics Inc 10-K, 10-Q, 8-K Forms - Stock Titan
Bluejay Diagnostics, Inc. Enters Securities Purchase Agreement for $25,000 Private Placement of Common Stock - Minichart
Bluejay Diagnostics Announces Insider-Funded Private Stock Placement - TipRanks
Bluejay Diagnostics completes $125,000 private placement with board members - Investing.com
Bluejay Diagnostics Raises $125,000 in Insider Private Placement at $2.00 Per Share - TradingView
Bluejay Diagnostics (NASDAQ: BJDX) insiders purchase $125K in private stock deal - Stock Titan
Fed Meeting: Is Bluejay Diagnostics Inc gaining market shareEntry Point & Weekly Return Optimization Alerts - baoquankhu1.vn
Bluejay Diagnostics, Inc. announced that it has received $0.125 million in funding - marketscreener.com
Bluejay Diagnostics Evaluates Potential Acquisition Opportunity While Prioritizing Core Critical Care Platform Initiatives - Minichart
Bluejay Diagnostics sends response letter to NorthStrive Fund II LP By Investing.com - Investing.com India
Bluejay Diagnostics sends response letter to NorthStrive Fund II LP - Investing.com
Bluejay Weighs Proposed Therapeutic Acquisition, Reaffirms Symphony Focus - TipRanks
Bluejay responds to investor on possible therapeutic acquisition while prioritizing Symphony platform execution - TradingView
Bluejay Diagnostics (BJDX) reviews NorthStrive proposal for cough therapy acquisition - Stock Titan
Buyout Rumor: What is Bluejay Diagnostics Incs book value per shareTrade Exit Summary & Real-Time Volume Analysis - baoquankhu1.vn
Bluejay Diagnostics, Inc. announced that it expects to receive $0.125 million in funding - marketscreener.com
Bluejay Advances Symphony IL-6 Sepsis Diagnostic Program - TipRanks
Bluejay Diagnostics: SYMON-I IL-6 Findings Accepted for SAEM 2026 Presentation - TradingView
Bluejay Diagnostics (NASDAQ: BJDX) highlights SYMON-I IL-6 sepsis data at 2026 SAEM - Stock Titan
Bluejay Diagnostics to Present Findings on IL-6 as a Biomarker for Sepsis at 2026 SAEM Annual Meeting - Quiver Quantitative
Bluejay Announces Abstract Accepted for Presentation at the 2026 Society of Academic Emergency Medicine (SAEM) Annual Meeting - The Manila Times
Study explores link between ER inflammation marker and organ damage in sepsis - Stock Titan
Northstrive Fund II has sent a letter to the Board of Directors of Bluejay Diagnostics Inc, recommending that they carefully evaluate a potential acquisition opportunity. - Bitget
NorthStrive Fund II LP Issues Open Letter to the Board and Shareholders of Bluejay Diagnostics - The Manila Times
Braeden Lichti Pushes for Changes at Bluejay Diagnostics with 3.65% Stake - TradingView
Activist investor presses deal at Bluejay Diagnostics (NASDAQ: BJDX) - Stock Titan
Activist investor files 13D in Bluejay Diagnostics (BJDX), pushes biotech acquisition review - Stock Titan
Investor presses Bluejay Diagnostics (NASDAQ: BJDX) on biotech acquisition idea - Stock Titan
Bluejay Diagnostics Provides Corporate Update and 2026 Strategic Outlook - marketscreener.com
Aug Opening: Is Bluejay Diagnostics Inc a good ESG investmentMarket Sentiment Report & Technical Pattern Based Buy Signals - baoquankhu1.vn
Bluejay 10-K: Net loss $6.85M, operating loss $6.95M; cash through Q3 2026 - TradingView
Medical diagnostics company Bluejay Diagnostics Inc (stock code: BJDX) is facing financial pressure. According to the company's latest disclosed financial plan, in order to maintain normal operations and advance R&D projects, it must secure at least $20 milli - Bitget
Bluejay Diagnostics says SYMON II study ‘progressing as planned’ - TipRanks
Bluejay’s 20-minute sepsis test drives 2026 plan and $20M cash goal - Stock Titan
Bluejay Diagnostics, Inc. Auditor Raises 'Going Concern' Doubt - marketscreener.com
BJDX Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
BJDX Earning Date, Earning Analysis and Earning Prediction - Intellectia AI
BJDX Should I Buy - Intellectia AI
ARMISTICE CAPITAL, LLC Acquires Shares in Bluejay Diagnostics Inc - GuruFocus
BJDXBluejay Diagnostics Inc Latest Stock News & Market Updates - Stock Titan
Why is Bluejay Diagnostics Inc. stock going downWeekly Trade Summary & Reliable Momentum Entry Alerts - mfd.ru
Bluejay Diagnostics Completes Warrant Exercises, Clarifies Capital Structure - TipRanks
Bluejay Diagnostics clears prefunded warrants after full exercise - MSN
Bluejay Diagnostics says all prefunded warrants exercised; ~972,000 shares outstanding, 1.5M cash-exercise warrants - TradingView
Bluejay Diagnostics’ Clinical Study Marks Key Transition from Enrollment to Data Analysis - StocksToTrade
Prefunded warrants fully exercised at Bluejay Diagnostics (NASDAQ: BJDX) - Stock Titan
Bluejay Diagnostics completes prefunded warrant exercises By Investing.com - Investing.com Canada
Bluejay Diagnostics Announces Full Exercise of Prefunded Warrants and Current Share Structure Update - Quiver Quantitative
Bluejay Diagnostics Announces All Prefunded Warrants Now Exercised - marketscreener.com
Medical diagnostics firm ends prefunded warrants, flags 13G share confusion - Stock Titan
Why Etsy Shares Are Trading Higher By Over 15%; Here Are 20 Stocks Moving Premarket - Benzinga
Bluejay Diagnostics Inc Stock (BJDX) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.53%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):